← Back to Browse

Qiagen N.V.

QGEN • Healthcare

Compare

About Qiagen N.V.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids;...

Current Price
$41.51
Market Cap
$9.8B

Quality Assessment

Qiagen N.V. is a above-average quality healthcare company with a Compass Score of 74. Solid fundamentals, with a few weaker spots. Worth a look for a diversified portfolio.

Score Breakdown

The Compass Score is based on 6 quality factors identified by academic research.

Click any factor to see detailed metrics

Valuation Metrics

Click any metric for details

Fair Value

Pro

See whether this stock trades above or below its fair value.

Wall Street View

Consensus
Buy
Analysts
11
Price Target
๐Ÿ”’
Upside
๐Ÿ”’

Catalyst Signal

Plus

Recent earnings beats and analyst-upgrade momentum. How it works

Catalyst Score
๐Ÿ”’
EPS Beat Streak
๐Ÿ”’
Net Upgrades (180d)
๐Ÿ”’

See recent earnings beats and analyst-upgrade momentum.

Analyst Track Record

Plus

See each covering analyst's historical hit rate.

Financial Health

Plus

Click any metric for details

See bankruptcy-risk and financial-strength scores for this company.

Growth Projections

Plus
Projected EPS Growth
๐Ÿ”’
Projected Revenue Growth
๐Ÿ”’

See projected EPS and revenue growth for this company.

Technical Overview

Click any metric for details

Important Disclaimer

The Compass Score is for educational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always do your own research and consider consulting a financial advisor before making investment decisions.